Based on the ability of bile acids for vectorializing the cytostatic activi
ty of other agents, we have designed and synthesized a new bile acid cholyl
glycinato Au(III) complex, named Bamet-Al. It has been characterized by mea
ns of EA (elemental analysis), FT-IR, NMR. FAB-MS (fast atom bombardment-ma
ss spectrometry) and Vis-UV techniques. This characterization allowed us to
propose a structure of the type [AuCG(O) CG(N,O) Cl] for the neutral compl
ex, which has the composition C52H84N2O12AuCl and is very soluble in water,
methanol, ethanol and DMSO (dimethylsulfoxide). The study in aqueous solut
ion suggested a redox process for its transformation, which is accompanied
by the appearance of colloidal gold phase. The behavior in 4 mM NaCl water
tin order to mimic the cytoplasmatic fluid) was similar to that observed in
water, while in a 150 mM NaCl (similar to extracellular fluid and serum),
the apparition of a dark blue precipitate was observed. This complex displa
ys fluorescence. which does not change when incubated with DNA obtained fro
m E. coli. Bamet-Al was found to inhibit the growth of a variety of cell li
nes. The cytostatic effect was mild against human hepatoma HepG2. mouse hep
atoma Hepa 1-6. rat hepatoma McA RH-7777 and human colon adenocarcinoma LS-
174T. and stronger against mouse sarcoma S180-II and mouse leukemia L-1210
cells. The appearance of colloidal Au during the process of hydrolysis unde
r physiological conditions may explains the low cytostatic activity. (C) 20
01 Elsevier Science B.V. All rights reserved.